版本:
中国

BRIEF-Vifor Pharma says CHMP recommends Veltassa for treatment of hyperkalaemia in EU

May 19 VIFOR PHARMA LTD (IPO-VIFP.S):

* CHMP RECOMMENDS VELTASSA FOR TREATMENT OF HYPERKALAEMIA IN EU

* FINAL EU COMMISSION DECISION EXPECTED IN Q3 2017 Source text for Eikon: Further company coverage: (Gdynia Newsroom)

我们的标准: 汤森路透“信任原则

更多 瑞士市场报道

热门文章

编辑推荐

文章推荐